BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16105195)

  • 1. Fatal Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral therapy.
    Kawsar M
    Int J STD AIDS; 2005 Aug; 16(8):582-3; author reply 583. PubMed ID: 16105195
    [No Abstract]   [Full Text] [Related]  

  • 2. Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral treatment initiation.
    Chan DJ
    Int J STD AIDS; 2006 Jan; 17(1):72. PubMed ID: 16409689
    [No Abstract]   [Full Text] [Related]  

  • 3. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
    Loke WC; Spittle MF; Mitchell S; Kulasegaram R
    Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
    Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
    Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS associated Kaposi's sarcoma.
    Thomas S; Sindhu CB; Sreekumar S; Sasidharan PK
    J Assoc Physicians India; 2011 Jun; 59():387-9. PubMed ID: 21751599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy.
    Connick E; Kane MA; White IE; Ryder J; Campbell TB
    Clin Infect Dis; 2004 Dec; 39(12):1852-5. PubMed ID: 15578411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly active antiretroviral therapy for the treatment of Kaposi's sarcoma associated with primary human immunodeficiency virus type-1 infection.
    Genka I; Yasuoka A; Saitoh K; Oka S
    Jpn J Infect Dis; 2000 Aug; 53(4):166-7. PubMed ID: 11056560
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal Kaposi's sarcoma-associated immune reconstitution following HAART initiation.
    Crane HM; Deubner H; Huang JC; Swanson PE; Harrington RD
    Int J STD AIDS; 2005 Jan; 16(1):80-3. PubMed ID: 15705280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of Kaposi's sarcoma lesions following highly active antiretroviral therapy in an HIV-infected patient.
    Kumarasamy N; Venkatesh KK; Devaleenol B; Poongulali S; Ahilasamy N
    Int J STD AIDS; 2008 Nov; 19(11):786-8. PubMed ID: 18931277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does HAART lead to the resolution of Kaposi's sarcoma?
    Stebbing J; Portsmouth S; Gazzard B
    J Antimicrob Chemother; 2003 May; 51(5):1095-8. PubMed ID: 12668573
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma.
    Stebbing J; Gazzard B; Flore O; Thomas C; Benlahrech A; Mandalia S; Bower M; Gotch F; Patterson S
    AIDS; 2003 Sep; 17(13):1998-2000. PubMed ID: 12960839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's sarcoma, lymphoedema and gangrene in AIDS--a therapeutic challenge.
    Ebrahim S; Singh B; Moodley J; Ramdial PK
    S Afr J Surg; 2009 May; 47(2):62-3. PubMed ID: 19626783
    [No Abstract]   [Full Text] [Related]  

  • 14. Trends in Kaposi's sarcoma survival disparities in the United States: 1980 through 2004.
    Datta GD; Kawachi I; Delpierre C; Lang T; Grosclaude P
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2718-26. PubMed ID: 20861396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-cancer agents. Kaposi's sarcoma--past and future.
    TreatmentUpdate; 2008; 20(5):3-5. PubMed ID: 19248278
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytokine pattern in Kaposi's sarcoma associated with immune restoration disease in HIV and tuberculosis co-infected patients.
    Tamburini J; Grimaldi D; Chiche JD; Bricaire F; Bossi P
    AIDS; 2007 Sep; 21(14):1980-3. PubMed ID: 17721110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma in pregnancy after initiation of highly active antiretroviral therapy: a manifestation of immune reconstitution syndrome.
    Adeyemo A; Wood C; Govind A
    Int J STD AIDS; 2012 Dec; 23(12):905-6. PubMed ID: 23258835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi's sarcoma in the era of HAART-an update on mechanisms, diagnostics and treatment.
    Dittmer DP; Vahrson W; Staudt M; Hilscher C; Fakhari FD
    AIDS Rev; 2005; 7(1):56-61. PubMed ID: 15875661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of HAART on AIDS-related Kaposi's sarcoma and non-Hodgkin's lymphoma.
    Clayton G; Omasta-Martin A; Bower M
    J HIV Ther; 2006 Sep; 11(3):51-3. PubMed ID: 17580498
    [No Abstract]   [Full Text] [Related]  

  • 20. AIDS-associated Kaposi's sarcoma associated with a low viral load and a high CD4 cell count.
    Stebbing J; Powles T; Bower M
    AIDS; 2008 Feb; 22(4):551-2. PubMed ID: 18301078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.